# Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors

> **NCT06470997** · — · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 60 (estimated)

## Conditions studied

- Immune-mediated Hepatitis

## Interventions

- **BIOLOGICAL:** Blood sample collection
- **PROCEDURE:** Liver biopsy

## Key facts

- **NCT ID:** NCT06470997
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-17
- **Primary completion:** 2027-01-18
- **Final completion:** 2027-01-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06470997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06470997, "Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06470997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*